THE COMPARATIVE EVALUATION OF RADIOTHERAPY WITH CONCURRENT WEEKLY CISPLATIN VERSUS CONCURRENT 3-WEEKLY CISPLATIN AND ETOPOSIDE IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED NON SMALL CELL LUNG CANCER

被引：0
|
作者：
Bagri, P. K. [1 ]
Hirapara, P. [1 ]
Kapoor, A. [1 ]
Singhal, M. [1 ]
Singh, D. [1 ]
Jakhar, S. L. [1 ]
Beniwal, S. K. [2 ]
Sharma, N. [1 ]
Kumar, H. [1 ]
Sharma, A. [1 ]
机构：
[1] Acharya Tulsi Reg Canc Treatment & Res Inst, Bikaner, India
[2] Acharya Tulsi Canc Treatment & Res Inst, Bikaner, India
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
87P
引用
收藏
页码：S35 / S36
页数：2
相关论文
共 50 条
  • [1] A comparative evaluation of radiotherapy with concurrent weekly cisplatin versus concurrent weekly paclitaxel in patients with locally advanced carcinoma cervix
    Bagri, P. K.
    Samdariya, S.
    Pareek, P.
    Khichar, S.
    Pareek, V.
    ANNALS OF ONCOLOGY, 2015, 26 : 80 - 80
  • [2] A COMPARATIVE EVALUATION OF RADIOTHERAPY WITH CONCURRENT WEEKLY CISPLATIN VERSUS CONCURRENT WEEKLY PACLITAXEL IN PATIENTS WITH LOCALLY ADVANCED CARCINOMA CERVIX
    Maurya, Neerja
    Singotia, Laxmi
    Saxena, A.
    Rawat, S.
    Pounikar, T.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (31): : 1667 - 1672
  • [3] Comparative evaluation of radiotherapy with concurrent weekly cisplatin versus concurrent daily erlotinib and weekly cisplatin in locally advance carcinoma cervix
    Rawat, S. J.
    Advait, M. K.
    Kirar, P.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S32 - S32
  • [4] Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer
    Espeli, V.
    Zucca, E.
    Ghielmini, M.
    Giannini, O.
    Salatino, A.
    Martucci, F.
    Richetti, A.
    ORAL ONCOLOGY, 2012, 48 (03) : 266 - 271
  • [5] Compliance, toxicity and efficacy in weekly versus 3-weekly cisplatin concurrent chemoradiation in locally advanced head and neck cancer
    Muzumder, Sandeep
    Srikantia, Nirmala
    Vashishta, Ganesha Dev
    Udayashankar, Avinash H.
    Raj, John Michael
    Sebastian, M. G. John
    Kainthaje, Prashanth Bhat
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2019, 18 (01) : 21 - 25
  • [6] Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer.
    Espeli, V.
    Zucca, E.
    Ghielmini, M. E. G.
    Richetti, A.
    Giannini, O.
    Martucci, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] CONCURRENT CHEMORADIATION WITH THREE WEEKLY VERSUS WEEKLY CISPLATIN IN LOCALLY ADVANCED NASOPHARYNGEAL CANCER PATIENTS
    Lee, Ji Yun
    Sun, Jong-Mu
    Kim, Sung-Bae
    Park, Keon Uk
    Kim, Hoon-Kyo
    Hong, Dae Sik
    Kim, Jun Suk
    Park, Keunchil
    Ahn, Yong Chan
    Ahn, Myung-Ju
    ANNALS OF ONCOLOGY, 2014, 25
  • [8] Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: A phase I study
    Comella, G
    Frasci, G
    Scoppa, G
    Guida, C
    Gravina, A
    Fiore, F
    Casaretti, R
    Daponte, A
    Ruffolo, P
    Comella, P
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 113 - 116
  • [9] CONCURRENT CISPLATIN AND ETOPOSIDE WITH RADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG-CANCER
    FRIESS, GG
    BAIKADI, M
    HARVEY, WH
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 681 - 684
  • [10] Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer
    Nakamura, Masaru
    Koizumi, Tomonobu
    Hayasaka, Munehara
    Yasuo, Masanori
    Tsushima, Kenji
    Kubo, Keishi
    Gomi, Kotaro
    Shikama, Naoto
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1091 - 1096
12345